SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-059964
Filing Date
2018-11-14
Accepted
2018-11-14 16:20:11
Documents
68
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv506447_10q.htm 10-Q 671323
2 EXHIBIT 31.1 tv506447_ex31-1.htm EX-31.1 8565
3 EXHIBIT 32.1 tv506447_ex32-1.htm EX-32.1 4498
  Complete submission text file 0001144204-18-059964.txt   8496120

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT imnp-20180930.xml EX-101.INS 2611674
5 XBRL TAXONOMY EXTENSION SCHEMA imnp-20180930.xsd EX-101.SCH 65610
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE imnp-20180930_cal.xml EX-101.CAL 49334
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE imnp-20180930_def.xml EX-101.DEF 431178
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE imnp-20180930_lab.xml EX-101.LAB 428079
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imnp-20180930_pre.xml EX-101.PRE 460259
Mailing Address 1 BRIDGE PLAZA N, SUITE 270 FORT LEE NJ 07024
Business Address 1 BRIDGE PLAZA N, SUITE 270 FORT LEE NJ 07024 201-464-2677
IMMUNE PHARMACEUTICALS INC (Filer) CIK: 0001208261 (see all company filings)

IRS No.: 521841431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36602 | Film No.: 181184113
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1